Cancer Family
Thymus Epithelial Neoplasm
CI-CAN-00000365Explore in graph →
Non-malignant39 active trials1 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000365Explore in graph →
Clinical trials
136 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02633514 | Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma | withdrawn | Phase 3 | 0 | Fudan UniversityOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT04985357 | Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs | withdrawn | — | 0 | Travera IncINDUSTRY | 0 | Nov 25, 2024 | clinicaltrials |
| Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.(PUTNET) |
| withdrawn |
| Phase 2 |
| 0 |
| Excel Diagnostics and Nuclear Oncology CenterOTHER |
| 1 |
| Mar 10, 2023 |
| clinicaltrials |
| NCT04371458 | Thymectomy With and Without Povidone-iodine Pleural Lavage in Stage IVA Thymic Malignancies | withdrawn | Phase 1 / Phase 2 | 0 | Yale UniversityOTHER | 0 | Jul 25, 2022 | clinicaltrials |
| NCT02948855 | Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases | withdrawn | — | 0 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 18, 2018 | clinicaltrials |
| NCT02831179 | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor | withdrawn | Phase 1 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Sep 28, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Apr 27, 2026source: clinicaltrials